II, I., H, D., RF, B., V, V., H, H., C, S., . . . K, D. (2024). CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. Cancers, 16(13), . https://doi.org/10.3390/cancers16132437
Chicago Style (17th ed.) CitationII, Issa, et al. "CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma." Cancers 16, no. 13 (2024). https://doi.org/10.3390/cancers16132437.
MLA (9th ed.) CitationII, Issa, et al. "CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma." Cancers, vol. 16, no. 13, 2024, https://doi.org/10.3390/cancers16132437.